About Corlieve Therapeutics SAS
Based in Paris, Corlieve Therapeutics SAS operates in the Life Science sector. Investors on record include uniQure N.V. and uniQure Biopharma BV. Founded in 2019, it is headquartered in Paris. Corlieve Therapeutics SAS is included in the Acquity Data private market database.